← Browse by Condition
Medical Condition
breast cancer early breast cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT05774951 Phase 3
Recruiting
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Enrollment
4,300 pts
Location
United States, Argen...
Sponsor
AstraZeneca
NCT07331506
Recruiting
Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Enrollment
300 pts
Location
Argentina
Sponsor
Oncoliq US Inc